echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Teyi Pharmaceutical's compound sulfamethoxazole tablets passed the consistency evaluation of generic drugs

    Teyi Pharmaceutical's compound sulfamethoxazole tablets passed the consistency evaluation of generic drugs

    • Last Update: 2021-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On October 21, Teyi Pharmaceuticals issued an announcement stating that the company had recently obtained the "Notice of Supplementary Application Approval for Compound Sulfamethoxazole Tablets" approved and issued by the National Medical Products Administration.


    Compound sulfamethoxazole tablets are sulfa antibacterial drugs, which are a compound preparation of sulfamethoxazole (SMZ) and trimethoprim (TMP).


    Compound sulfamethoxazole tablets are national essential drugs, Class A drugs in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2020)"


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.